Canada Day 2026: The Road We’ve Travelled

On this Canada Day we’d like to reflect on the road legalized cannabis has travelled in Canada so far.

2001: Medical Cannabis Framework Evolution

The Marihuana Medical Access Regulations (MMAR) came into force on July 30, 2001. This was Canada’s original medical cannabis framework, establishing the first legal pathways for patient possession and personal production licenses. MMAR was created to give patients a secure, legal supply of cannabis if they suffered from terminal illnesses or severe chronic conditions (like multiple sclerosis, spinal cord injuries, or severe arthritis). Before the MMAR, possessing or producing cannabis for any reason was strictly a criminal offense. The MMAR changed the legal landscape by establishing that Canadians had a constitutional right to access cannabis if a physician deemed it medically necessary.

2013: Marihuana for Medical Purposes Regulations (MMPR)

While groundbreaking, the MMAR model faced several practical challenges, so Health Canada decided to phase out the MMAR and transition to a commercialized, highly regulated system with strict quality control. This led to the creation of the MMPR, which removed home-grows entirely and birthed the modern “Licensed Producer” (LP) industry that exists today.
The initial implementation of MMPR occurred on June 19, 2013. This regulation created the commercial framework, shifting production away from home-grows toward a regulated network of licensed commercial producers (LPs). MMPR fully replaced MMAR April 1, 2014.

2016: Access to Cannabis for Medical Purposes Regulations (ACMPR)

ACMPR was announced August 11, 2016 and came into Force: August 24, 2016 and was enacted following the Allard v. Canada court ruling. This framework combined the commercial LP structure of the MMPR while restoring the legal right for authorized patients to grow a limited supply at home.

2017: Cannabis Act (Bill C-45)

The Cannabis Act established the framework for recreational (adult-use) cannabis in Canada. Bill C-45 was passed by the House of Commons on November 27, 2017, with the final senate vote on June 19, 2018. The act received Royal Assent and became law. on June 21, 2018, but officially came into force on October 17, 2018, known as Legalization Day in Canada.
This officially replaced the previous medical regulations (subsuming medical access under the broader Cannabis Act) and fully legalized adult-use recreational dried flower and oils nationwide.

2019: Amended Cannabis Regulations (“Cannabis 2.0”)

Exactly one year later, on October 17, 2019, amendments legally permitted the production, distribution, and sale of alternative product formats, specifically edibles, extracts, and topicals.

2022: The Beverage Equivalency “Math Fix”

Early regulations suffered from a flawed math formula regarding public possession limits for liquid cannabis beverages. In December 2022 Health Canada corrected the formula, unlocking the commercial potential of the cannabis beverage category.

2025: “Omnibus” Regulatory Streamlining

Following the independent Expert Panel’s legislative review, Health Canada introduced a massive regulatory relief package to alleviate administrative burdens on Licensed Producers (LPs).

2026: Packaging and Labelling Modernization

In March 2026, a major shift in packaging rules hit full enforcement. The initial, heavily restrictive “plain packaging” mandates were updated to support eco-friendly initiatives and better consumer education.

2026: Mature Market

Today, the cannabis market in Canada is a highly mature, disciplined industry focused on margin protection and hyper-localized supply chains. Statistics Canada figures show that small independent operators form the true backbone of the market—over 51% of legal retail stores employ fewer than four people, and micro-cultivation licenses remain the most popular category. General volume-driven cannabis has faced heavy price compression. To survive, smaller cultivators are relying on hands-on methods (hand-trimming, hang-drying, rare genetics) to earn formal “Craft” designations. Where provincial frameworks allow, micro-producers and boutique processors are shifting away from massive central distribution hubs to utilize direct-delivery capabilities, connecting directly with independent retail networks to protect product freshness and margins.

To read Health Canada’s deep dive into the legislative background, policy goals, and public health data compiled since 2018, review the Government of Canada Cannabis Act Progress Report. https://www.canada.ca/en/health-canada/programs/engaging-cannabis-legalization-regulation-canada-taking-stock-progress/document.html

For a highly detailed chronological deep dive into the country’s drug legislative changes stretching back to 1908, read the Wikipedia Legal History of Cannabis in Canada Page. https://en.wikipedia.org/wiki/Legal_history_of_cannabis_in_Canada

To explore how public opinion shifted and understand the social factors that ultimately influenced the federal government to draft Bill C-45, see The Canadian Encyclopedia Legalization Summary. https://thecanadianencyclopedia.ca/en/article/marijuana-legalization-in-canada

To listen to or read an exploration of how a virtually unknown plant became a multibillion-dollar legal market after nearly a century of bans, check out the CBC Radio: The Long, Strange Story of Pot Prohibition in Canada feature. https://www.cbc.ca/radio/ondrugs/the-long-strange-story-of-pot-prohibition-in-canada-1.4541890


Cultivating Total Visibility with AirMed

The true cost of cannabis production extends beyond genetics. Expenses are anchored in facility overhead, specialized nutrients, custom substrates, and packaging components.

Operational accounting requires a framework linking consumables to lineage. Tracking nutrients, substrates, and packaging to lots transforms calculation into science.

When every millilitre of nutrient, millimetre of substrate, and unit of packaging is tracked directly against specific lots, your cost-per-gram calculation transforms from a rough estimate into an exact science. Linearly tying these facility consumables to your standard plant records provides granular visibility, ensuring that a spike in a specific raw material’s cost doesn’t silently erode your bottom line.

AirMed closes the visibility gap by integrating your non-cannabis inventory. Our software logs and monitors non-cannabis inputs such as growth media, substrates, and fertilizers.
This comprehensive ecosystem helps producers:

  • Forecast: Anticipate material requirements for cycles, optimizing supply needs via history.
  • Prevent Stockouts: Set alerts for nutrients, labels, or packaging components, keeping workflows moving without halts.
  • Track ROI: View cost data by the gram, helping teams identify profitability across strains.

By tracking all materials from the moment they enter your facility until they are consumed in your production lines, AirMed provides real-time oversight.

Read more about our inventory management here: https://airmedcloud.com/airmed-inventory-management/ 

For more information visit our Software page.


Hemp Regulations: Government of Canada Consultation until June 30

The Government of Canada is inviting comment on potential amendments to the Industrial Hemp Regulations. The amendments aim to reduce regulatory requirements and administrative burden, while continuing to meet our public health and public safety objectives.

“These changes would support our commitment to reducing regulatory red tape, while maintaining key control measures for industrial hemp.”

The focus of this consultation includes the following stakeholders.

  • current and potential industrial hemp licence holders
  • industrial hemp industry associations
  • cannabis licence holders
  • cannabis industry associations
  • Indigenous groups
  • professional associations
  • federal partners (departments and agencies)
  • provinces and territories

The Notice of Intent was published in the Canada Gazette, Part I on May 16, 2026 and the deadline to submit comments is June 30, 2026.

To participate, send your comments in an email to cannabis.consultation@hc-sc.gc.ca. Use the subject line: “Consultation on potential amendments to the Industrial Hemp Regulations”.

For  more information visit: Government of Canada

To read the official announcement visit: Government of Canada Gazette


Profile: Retail Cannabis Council of Manitoba

The Retail Cannabis Council of Manitoba (RCCMB) is the unified, non-partisan advocate for independent cannabis retailers across the province, dedicated to fostering a safe, equitable, and sustainable industry. We serve as a respected voice at the local, provincial, and national government levels, actively representing retailers in discussions regarding legal and regulatory frameworks.

The mission of the RCCMB is to empower independent business owners by ensuring their interests are prioritized before regulatory changes are enacted. By advocating for fair regulations, the elimination of red tape, and the eradication of the illicit market, we work to cultivate a legal cannabis sector that benefits communities, businesses, and consumers alike.

The Council is committed to advancing the interests of its members by providing essential representation, shaping policies that encourage sector growth, and promoting high-quality, safe industry standards.

Through collaboration with government bodies, industry stakeholders, and the public, the RCCMB fosters an environment where independent cannabis retailers can thrive while contributing to a responsible and robust provincial market.

For more information please visit: https://rccmb.ca/


Enhancing the Medical Cannabis Patient Journey

As the Canadian cannabis industry continues to mature, we are witnessing a renewed focus on the medical sector. While recreational retail often captures the spotlight, the medical market remains a vital pillar of the industry, characterized by a patient base that prioritizes consistency, reliability, and professional service. In this landscape, technology is doing more than just tracking plants; it is becoming a critical tool for enhancing the “human side” of patient care.

Bridging the Gap with Integrated Portals

The initial interaction between a patient and a Licensed Producer (LP) often happens within a digital portal. Historically, these were simple e-commerce sites, but today, they have evolved into sophisticated interfaces. By integrating these portals directly into a seed-to-sale management system, LPs can streamline the medical document verification and registration process.

For a patient seeking relief, a delay in paperwork can be a significant barrier. Modern software ensures that onboarding is efficient and accurate, allowing patients to access their medicine without unnecessary administrative friction. When the technology works seamlessly in the background, the LP can spend less time on data entry and more time on patient support.

Transparency and Trust through Real-Time Data

One of the most significant benefits of modern software is the ability to provide transparent, real-time inventory levels via API (Application Programming Interface) integrations. For medical patients—many of whom rely on specific terpene profiles or cannabinoid ratios for chronic conditions—knowing that their medicine is in stock is essential for peace of mind.

When an LP’s internal inventory system communicates directly with the patient-facing shop, it eliminates the frustration of “out-of-stock” surprises after an order has been placed. This transparency builds long-term trust. A patient who knows they can rely on their provider for a consistent supply is a patient who remains loyal.

Personalized Care through CRM Tools

Behind the scenes, Customer Relationship Management (CRM) tools are helping LPs move away from a “one-size-fits-all” approach. By securely analyzing patient preferences and order histories, providers can offer helpful, personalized resources, such as educational content relevant to a patient’s specific needs or notifications when a preferred strain is back in stock.

This proactive communication demonstrates that the LP views the patient as an individual rather than just a number in a database. Patient retention is a natural byproduct of a supportive, tech-enabled experience. By using digital tools to remove obstacles and provide clear information, the industry is ensuring that medical cannabis remains an accessible and reliable option for all Canadians.

View our demo sites that show integration with our database and a Word Press website using our API and proprietary WP plug-in.

Home

Home

For more information visit our Software page.


Tax Reform Advocacy in Canada’s Cannabis Industry

On April 23, 2026, the Cannabis Council of Canada (C3)—the national voice for Canada’s licensed producers and processors—submitted a significant update to the Office of the Commissioner of Lobbying. This isn’t just another routine filing; it is a formal, data-backed demand for the federal government to address the “punitive” tax regime that is currently stifling the legal market.

C3 is actively engaging with departments like Finance Canada and Innovation, Science and Economic Development (ISED) to deliver a clear message: The tax framework built in 2018 is broken, and 2026 must be the year it is fixed.

The core of C3’s argument centres on a massive disconnect between policy intent and practical reality. When legalization was first proposed, the excise tax was intended to be $1 per gram or 10% of a producer’s sale price—whichever was higher. The assumption was that wholesale prices would remain high enough that 10% would be the standard.

However, as wholesale prices have dropped to accommodate a competitive legal market, that “fixed” $1 per gram has become a heavy weight. C3’s latest filing highlights that for many high-volume, value-tier products, the excise tax now effectively hits nearly 30% of gross revenue. This “Excise Gap” is the primary reason many LPs are struggling with financial sustainability while the illicit market continues to operate tax-free.

As we move through 2026, C3’s work in Ottawa will be the most important story for every producer in the country. It’s time for a tax framework that reflects the reality of the market today, not the guesses made eight years ago.

You can support the Cannabis Council of Canada by visiting their Advocacy Hub where you can find resources to help educate your local MP and community about the need for a sustainable excise cap. https://www.cannabis-council.ca/advocacy


Profile: Cannabis Council of Canada

The Cannabis Council of Canada (C3) is the national and international voice for Canada’s licensed cannabis producers and processors, advocating for a safe, competitive, and responsible industry. We promote high standards, foster economic growth, and work to ensure integrity within the regulated market. By advocating for fair regulations, high-quality standards, and economic opportunities, we work to ensure public safety, and foster a legal market that benefits communities, businesses, and consumers alike. Committed to eliminating the illicit market, we strive to strengthen Canada’s legal cannabis sector while driving innovation and economic opportunities. As the trusted national resource on the Canadian Cannabis industry, we engage with stakeholders to support the industry’s continued development and responsible use for both medical and recreational purposes.

The mission of the Cannabis Council of Canada is to advocate for and promote a healthy, trusted, and competitive cannabis market that empowers Canada’s Licensed Producers to deliver high-quality, rigorously tested products to consumers while ensuring long-term financial sustainability.

The C3 Advocacy Roadmap

C3’s mission in 2026 is built on three specific pillars of reform aimed at stabilizing the sector:

The 10% Ad Valorem Cap: C3 is lobbying to replace the $1-per-gram minimum with a hard cap at 10% of the producer’s selling price. This would immediately restore margins and allow legal producers to compete fairly on price.

National Stamp Harmonization: Currently, producers must navigate a logistical nightmare of province-specific excise stamps. C3 is pushing for a single national stamp to streamline supply chains and reduce operational costs.

The Medical Exemption: A renewed effort to eliminate excise tax on medical cannabis, ensuring that patients aren’t taxed for accessing their medication.

The Cannabis Council is committed to advancing the interests of its members by providing essential industry resources, engaging with policymakers to shape fair and progressive regulations, and championing policies that encourage sector growth while reducing unnecessary operational and financial burdens.

Through collaboration with industry stakeholders, government bodies, and the public, the Council fosters an environment where innovation, consumer safety, and responsible business practices drive the future of Canada’s legal cannabis industry.

For more information please visit: https://www.cannabis-council.ca/


Grow Up Toronto 2026 Conference: June 1-3

The Grow Up Conference and Expo returns to Toronto this June, providing a focused environment for cannabis growers, brands, and retailers to connect. This event is widely regarded as one of Canada’s largest gatherings for the cultivation and extraction sectors. Attendees can expect a comprehensive schedule that includes over 60 sessions and panels led by more than 140 industry experts covering the latest in cultivation technology, regulatory changes, and market trends.

The 2026 edition features several high-value zones and workshops specifically for producers. The Brands and Buyers zone is designed to facilitate direct meetings between licensed producers and retail purchasing agents to streamline wholesale opportunities.

Additionally, the event offers Masterclass technical workshops that provide in-depth training on advanced cultivation and extraction techniques. The CannaVision Executive Summit on June 1st will also address strategic leadership and global market shifts for C-level executives and decision-makers.

This event is hosted by Grow Up Conference and Expo, a Canadian-owned and operated organization that has been focusing on the cannabis industry’s growth and innovation since 2017. The event will take place at the Metro Toronto Convention Centre in downtown Toronto.

For more information visit: https://growupconference.com/


How Automation in Cannabis Operations Can Save Time and Reduce Costs

Automation in cannabis operations can streamline a variety of repetitive, time-consuming tasks—from inventory tracking to compliance reporting—helping businesses operate more efficiently and reduce the risk of human error. By automating these tasks, companies can free up valuable time and resources, which can then be focused on growing the business and improving customer experiences.

Reducing Time-Consuming Manual Processes

For many cannabis businesses, managing inventory is one of the most complex and time-consuming tasks. Manual tracking of inventory, product movements, and sales data can result in errors, delays, and inefficiencies. Automation solves this problem by enabling real-time updates of inventory levels, tracking product movements from seed to sale, and generating automatic alerts when stock is low or when products need restocking. This ensures that businesses have an accurate view of their inventory at all times, reducing the likelihood of stockouts or overstocking, both of which can have negative financial implications.

Simplifying Compliance and Reporting

Cannabis businesses are subject to numerous regulations, and staying compliant is essential. However, manually tracking compliance requirements can be overwhelming, especially with the constant changes in laws and regulations. Automation makes compliance easier by automatically generating the necessary reports, tracking product testing, and ensuring all documentation is in order. This not only saves time but also reduces the risk of non-compliance, which can lead to hefty fines or even the loss of business licenses.

Scaling Operations Without the Added Overhead

As businesses grow, manual processes can become bottlenecks that prevent further scaling. Automation helps cannabis companies scale operations without the need for additional staff or resources. Whether it’s automated inventory management, sales reporting, or compliance checks, automation allows businesses to expand without the added overhead of manual systems. This scalability makes it easier for businesses to meet the demands of a growing market while keeping costs under control.

How AirMed Can Help

Our cannabis management software is designed to automate many of the time-consuming tasks that businesses face. From inventory tracking and sales reporting to automated compliance checks, AirMed helps you streamline your operations. By eliminating manual processes, you can not only save time and money but also ensure that you remain compliant with ever-changing regulations. AirMed lets you focus on what matters most—growth and customer satisfaction—while we take care of the back-end operations.

With AirMed, automation is no longer a luxury. By automating routine tasks, AirMed can help your cannabis businesses reduce costs, minimize human error, and scale operations more efficiently. Investing in automation tools is an investment in the future of your business.

Read more about our inventory management here: https://airmedcloud.com/airmed-inventory-management/ 

Learn about the AirMed automation features here: https://airmedcloud.com/airmed-5-templates/

For more information visit our Software page.


Canadian Cannabis Research Summit 2026: May 27-29 in Toronto

Canada’s most comprehensive forum on the science behind cannabis, its potential therapeutic benefits and the societal and health impacts of legalization of non-medical cannabis from leading researchers and physicians in the field.

Join the largest national gathering of Canadian cannabinoid medicine researchers, clinicians, trainees and allied healthcare practitioners that will showcase research being conducted from coast to coast. This event will also continue detailed discussions on the latest cannabinoid research, clinical care and future government policies.

This event is co-hosted with the Toronto Cannabis and Cannabinoid Research Consortium and is being held at Chestnut Conference Centre, 89 Chestnut St, Toronto, Ontario.

For more information visit: https://ccic.net/ccic-conference/


Report: Global Medical Cannabis 2026-2030

The Global Medical Cannabis Market Review examines the status and dynamics of the international medical cannabis supply chain, highlighting emerging developments and trends in key international markets.

Published by Prohibition Partners, the report provides country-specific data and analysis, comparing countries based on relevant metrics including volumes of exports and imports, market size, domestic production, product and distribution landscape.

Prohibition Partners was founded in 2017 with a vision for a legal cannabis industry where the abundant economic, societal and health benefits of the plant can be realised by people around the world. This report includes market sizing and patient population forecasts for 14 key international markets – from 2026-2030. Also included is graphical and narrative analysis of the market size and the driving forces behind growth. In addition, scenario forecasting for Australia & Germany will also be included.

The Review delves deeper into the driving forces behind international import and supply chain dynamics, as well as factors such as: domestic production capabilities in various countries, the impact of telemedicine on patient access and care, and recent regulatory changes that shape the landscape of medical cannabis. By analysing these elements, the Review aims to offer insights into market growth potential and the evolving global context of medical cannabis supply and demand.

For more information about this report, including a 45-page free download, visit:
https://prohibitionpartners.com/reports/global-medical-cannabis-market-review-2026/


Cannabis Europa London 2026: May 26-27

Join 1500 attendees, 70 speakers and 50 exhibitors in London this May for Cannabis Europa London 2026.

Cannabis Europa brings together the brightest minds in cannabis policy, business, and investment. Over two days in London, you’ll engage with policymakers, investors, scientists, and entrepreneurs to explore opportunities in one of the world’s fastest-evolving markets.

The speakers are global thought-leaders driving change in policy, research, and commerce. Hear their insights, challenge your thinking, and leave with actionable strategies.

From high-level policy debates to practical market strategies, Cannabis Europa London 2026 is designed to give you the knowledge and connections you need to lead.

For more information visit: https://www.cannabis-europa.com/


Meeting Health Canada Inspections in 2026

For Canadian licence holders, the “honeymoon phase” of legalization is firmly in the rear-view mirror. Health Canada recently finalized its compliance data for the 2024–2025 fiscal year. With nearly 900 inspections conducted, the data reveals a clear shift in regulatory focus. There was a marked increase in enforcement, with 37 non-compliant reports issued—nearly double the previous year.

What is driving this? While physical security and GAP (Good Agricultural Practices) remain stable, the majority of “Major Observations” now stem from Record Keeping and Data Integrity. Inspectors are no longer just checking if you have a record; they are checking if that record is contemporaneous and attributable.

Common pitfalls identified include the following

Incomplete Batch Records: Gaps in the “narrative” of a batch, specifically around sanitation and nutrient applications.

Traceability Lag: The inability to produce a full “seed-to-sale” history for a specific SKU within a reasonable timeframe during an unannounced visit.

Validation Gaps: Discrepancies between physical inventory and digital logs that suggest a lack of real-time data entry.

Compliance in 2026 is less about avoiding “bad” behaviour and more about proving “good” behaviour through data. As the regulator moves toward a risk-based model, facilities that can demonstrate a “system-first” approach to record-keeping are seeing fewer targeted inspections and smoother license renewals.

Moving forward, achieving a seamless Health Canada inspection requires a shift from reactive data management to a digital-first, continuous compliance model. AirMed software is specifically engineered to provide a unified system of record. Not only does our system let you track every action within the data fields, but we provide bi-directional traceability. And our Custom e-Form Builder provides further traceability, ensuring your facility remains in a state of permanent audit-readiness.

Our system is designed to eliminate the risk of human error and data discrepancies that often trigger regulatory flags. AirMed provides inspectors with immediate, transparent access to your operational history, item-by-item and action-by-action.


Stratcann’s Growing Relationships B2B Series: Calgary and Winnipeg

Hosted by StratCann, an organization dedicated to providing news and resources for the Canadian cannabis industry, the Growing Relationships event series returns this spring with one-day B2B gatherings in Calgary and Winnipeg.

These events are designed to foster direct connections between licensed producers, regional retailers, and industry service providers. Unlike larger trade shows, these regional sessions focus on intimate networking, brainstorming solutions for current industry challenges, and participating in community-led discussions.

The Calgary event takes place on April 29, 2026, at the Calgary Italian Cultural Centre.

The Winnipeg event follows on May 13, 2026, at the Norwood Hotel in the Promenade Ballroom.


Beyond the Plant: Managing Consumables & Nutrients for True Profitability

In the early days of legalization, the focus for most Canadian producers was simple: “How many grams can we grow?”

But as we move further into 2026, the question has evolved. In a market where quality is now the baseline and price compression is a constant reality, the most successful producers aren’t just tracking their plants—they’re tracking every drop of nutrient and every square inch of substrate.

To truly understand your cost-per-gram, you have to look beyond the plant. Here is how managing your consumables and nutrients with AirMed can turn “hidden costs” into your biggest competitive advantage.

The Hidden Cost of Guesswork

Nutrients, pesticides, and growing media represent one of the largest ongoing expenses in a facility. Yet, many producers still manage these using manual whiteboards or separate spreadsheets. This creates a “data silo” where you know how much you spent on nutrients this month, but you don’t know exactly which batch consumed them.

Preventing the “Friday Afternoon Stockout”

There is nothing more stressful than realizing you are out of a critical bloom booster or beneficial insect treatment on a Friday afternoon. For Micro Producers, who often operate with leaner inventories to preserve cash flow, a stockout can be devastating to a harvest cycle.

AirMed provides real-time visibility into your non-cannabis inventory. This ensures you only “pay for what you need,” keeping your capital focused on growth rather than sitting on a shelf as excess.

Sustainability & Environmental Reporting

Effective nutrient management isn’t just about saving money; it’s about social responsibility. By using AirMed to track your nutrient applications and runoff data, you create a digital trail that proves your commitment to 4R Nutrient Stewardship (Right Source, Right Rate, Right Time, Right Place). When it comes time for environmental reporting or applying for “Craft” or “Organic” certifications, your data is already organized and export-ready.

ROI: Linking Inputs to Outcomes

The ultimate goal of tracking consumables is to find your “sweet spot.” Does that expensive new terpene-enhancer actually result in a higher wholesale price for the final product? By linking your Inventory Ledgers with your nutrient logs, you can run an ROI analysis: Batch A (Standard Nutrients) vs. **Batch B (Premium Additives). Which one yielded a higher profit margin after all input costs were deducted?

Conclusion: Data is the New Fertilizer

In 2026, the producers who thrive will be the ones who treat their nutrients and consumables with the same level of scrutiny as their THC percentages. By integrating your consumable tracking into your AirMed workflow, you gain a 360-degree view of your facility’s health—and your bottom line.

Read more about our inventory management here: https://airmedcloud.com/airmed-inventory-management/ 

Learn about the AirMed Micro advantage for small producers: airmedmicro.com

For more information visit our Software page.


Profile: C-45 Quality Association

The C-45 Quality Association is committed to advancing excellence in Canada’s cannabis industry by promoting quality production practices, fostering sustainable and inclusive growth, and driving innovation. Through education, industry events, and strategic partnerships, we provide platforms for knowledge-sharing, professional development, and networking. We educate and inform consumers, producers, and regulators about the benefits of high standards, host events that bring together industry leaders and emerging voices, and offer resources that empower professionals at all levels to thrive. Our mission is to build a collaborative and resilient industry that reflects the highest quality, integrity, and continuous learning.

The Association strives to protect the public interest by engaging its members in the cannabis industry to arrive at sound practices that strengthen the industry and ensure safe and effective cannabis management throughout all of Canada, and globally, as the industry matures. The Association also endeavours to provide members with access to valuable knowledge, networks and resources that will assist members in improving and advancing their careers.

For more information please visit: https://www.cannabis-council.ca/


International Cannabis Business Conference 2026: April 13-15 in Berlin

The International Cannabis Business Conference (ICBC) Berlin 2026, held April 13–15 at the Estrel Berlin, remains the premier nexus for the global cannabis industry. As Europe’s largest business-to-business gathering, the event attracts over 5,000 participants from 80 countries, including high-level investors, policymakers, and medical professionals. Against the backdrop of Germany’s significant legal milestones, the conference offers a high-energy environment filled with expert-led panels on pharmaceutical innovation, adult-use regulations, and the latest cultivation technology. From the exclusive VIP opening reception to the sprawling trade show floor, ICBC provides an essential platform for networking, allowing attendees to secure international partnerships and navigate the complexities of a rapidly maturing market.

Cannabis policy modernization is sweeping across the European continent and Germany is at the forefront. Already home to the largest medical cannabis industry in Europe, Germany’s adult-use industry is ramping up after the first components of the CanG law were implemented at the start of April 2024. The International Cannabis Business Conference is once again bringing our flagship event to Berlin. This event is being held at Germany’s largest hotel and convention center, the Estrel Berlin Hotel.

For more information visit: https://ca.internationalcbc.com/


Canada’s Cannabis Sector Contributes $11.6 Billion to National GDP

Recent economic data from Stratcann and other sources indicates that the cannabis industry continues to be a significant driver of the Canadian economy.

In 2025, the sector’s total contribution to the national GDP reached approximately $11.6 billion. Notably, the licensed production and processing segment accounted for the vast majority of this impact, contributing $10.6 billion. This represents a steady increase over previous years, highlighting the industry’s maturation and its role as a more substantial economic contributor than several other traditional agricultural and beverage sectors.

The data underscores the long-term viability of the sector and provides a factual basis for ongoing discussions regarding industry regulation and economic policy. Licensed production now contributes more to the national GDP than industries such as air transportation and meat product manufacturing.

The data is primarily derived from Statistics Canada. The 11.6 billion dollar figure for 2025 is based on real-time and monthly gross domestic product data tracked by industry. These figures are calculated using chained 2017 dollars to provide a consistent comparison over time across various economic sectors. Another major source for these figures is a comprehensive economic study released in September 2025 titled High Impact, Green Growth: The Economic Footprint of Canada’s Cannabis Industry. This report was a collaborative effort between the Business Data Lab at the Canadian Chamber of Commerce and Organigram Global. While the study found an even higher total economic impact of 16 billion dollars when including indirect and induced effects, it used the raw underlying data provided by Statistics Canada to perform its modeling.


Framework for Clinical Trials: Government of Canada Consultation

Health Canada is seeking feedback on the proposed Clinical Trials Regulations for drugs (pharmaceuticals, biologics and radiopharmaceuticals) and on multiple guidance documents related to the proposal. The proposed framework would replace the clinical trial regulatory schemes for drugs in the following sections of the regulations:

Part C, Division 5 of the Food and Drug Regulations and
Part 2 of the Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations

This proposed framework aims to improve access to new and innovative therapies for people in Canada while maintaining strong safety protections for participants.

This initiative is part of Health Canada and the Public Health Agency of Canada’s work to streamline processes and enhance regulatory efficiency.

The consultation is open until March 20, 2026.


The Paperless Cannabis Facility: Why 2026 is the Year to Ditch the Binders

For years, the “compliance binder” has been a staple of the Canadian cannabis facility—a growing mountain of paper containing sanitation logs, visitor sign-in sheets, and equipment maintenance records. With Health Canada’s audit processes becoming more data-intensive and the margin for operational error shrinking, the risks of a paper-based system outweigh the perceived simplicity of a clipboard.

At AirMed, we believe that compliance shouldn’t be a chore that halts production. Here is how you can transform your facility into a streamlined, paperless operation using the advanced tools within the AirMed ecosystem.

The Power of the Custom e-Form Builder

One of the most transformative features of AirMed is our Custom e-Form Builder. While we introduced this functionality to help automate workflows, its true value in 2026 lies in total facility digitization.

Instead of manual logs that can be lost, stained, or misfiled, AirMed lets producers create digital versions of essential documents. For example, ensure staff are prompted to complete cleaning tasks at the right intervals, with digital timestamps that prove compliance. You can also track the “health” of your HVAC, irrigation, and lighting systems. And so much more.

By moving to a digital format, you don’t just save paper; you create a searchable database. If an auditor asks for the sanitation history of Room 4 from six months ago, you are a click away from a professional report, rather than a frantic search through a dusty filing cabinet.

Audit Readiness: From “Days of Prep” to “Real-Time”

We’ve often discussed the importance of Data-Driven Decision Making, but in the context of a paperless facility, data is your best defense. A traditional paper system is “reactive”—you only find errors when you review the logs.

AirMed shifts your facility to a “proactive” stance. Because our software is cloud-based and supports fully customizable tables, management can see in real-time which tasks have been completed and which are overdue. This level of transparency is exactly what Health Canada looks for during an inspection.

Scaling for Micros: Professionalism on a Budget

For micro-cultivators, the move to paperless is even more critical. AirMed Micro was purpose-built to provide the same award-winning platform used by Canada’s largest LPs but at a price point that fits a smaller scale. By utilizing the modular add-ons for Quality Management and Custom Forms, a micro producer can operate with the same level of regulatory sophistication as a large enterprise, without the need for a dedicated compliance department.

Integrating the Whole Operation

A paperless facility isn’t just about the grow rooms. It’s about how that data flows through the rest of your business. As we highlighted in our 2025 updates, AirMed’s integration with tools such as QuickBooks ensures that your records match your production perfectly. With our Inventory Ledgers and intelligent backdating, there’s no need to cross-reference a paper log with a digital sales order; the system does the heavy lifting for you.

Conclusion: A Competitive Advantage

In 2026, the most successful Canadian producers—whether large or small—will be those who treat compliance as a digital asset rather than a regulatory burden. Transitioning to a paperless facility with AirMed reduces human error, slashes the time spent on reporting, and ensures that when an auditor knocks, your facility is ready.

For more information visit our Software page.

You can also read a blog post about our form builder here: https://airmedcloud.com/custom-eform-builder-airmed-5/

And learn more about our inventory management here: https://airmedcloud.com/airmed-inventory-management/ 


Privacy Preference Center